Towards Precision Medicine for Immune-Mediated Disorders: Advances in Using Big Data and Artificial Intelligence to Understand Heterogeneity in Inflammatory Responses

143.3K

views

172

authors

19

articles

Editorial

22 June 2022

Editorial: Advances in Using Big Data and Artificial Intelligence to Understand Heterogeneity in Inflammatory Responses

Xu-jie Zhou

,

Amanda S. MacLeod

and

Lam Cheung Tsoi

1,777 views

3 citations

Editors

3

First Hospital, Peking University

University of Michigan

Amanda S MacLeod

Janssen Research and Development (United States)

Impact

About

The ability to understand the underlying mechanisms that drive the heterogeneity in inflammatory responses among patients suffering from immune-mediated conditions is critical. The nature of the immune mechanism ranges from the degree of immune cell activation, to the HLA genotypes, and the intensity of responses of target tissues to cytokines. High throughput experiments have generated significant information for us to facilitate the identification of disease-associated components for different complex immune-mediated conditions (e.g. psoriasis, lupus, rheumatoid arthritis, inflammatory bowel diseases), and the advances in biotechnologies and efficiency in computational resources have further promised cost-effective opportunities to simultaneously study the different aspects in the basic and translational domains of these human diseases. The critical questions we face are to provide efficient inference to integrate these datasets, and translate what we have learned from the disease-associated components to understand the heterogeneity (e.g. ethnic, gender, genetic differences) in disease manifestation and prognosis of these immune-mediated conditions. Translating and integrating big data to understand the intrinsic factors that shape the different unique natures of inflammation processes require an efficient and flexible framework to incorporate signatures of different types.

This Research Topic is intended to present and discuss technological, methodological, and conceptual advancements in immunological researches utilizing big data and/or new techniques to study the heterogeneity in immunological responses and clinical observations of immune-mediated disorders. We welcome the submission of Original Research, Systematic Review, Methods, Mini Review, Perspective, and Review articles, with potential topics including, but not limited to:

1. Designing efficient multi-omics studies for studying the pathophysiology of immune-mediated conditions

2. Advanced approaches to provide accurate and efficient HLA typing

3. Development of a generalizable and efficient framework to translate high throughput experimental data to study the variations in inflammatory responses

4. Multi-omics studies to unravel the signal transduction in the cytokine network

5. Providing a comprehensive understanding of the similarities and distinct biological features across different subgroups of patients suffering from immunological disorders

6. Applications of multi-omics to advance precision medicine in immune-mediated diseases

7. Novel in silico approaches to integrate omics information with electronic health record data

8. Machine learning tools to assess prognosis using patient’s healthcare records and/or -omic profiles

Topic Editor Dr. MacLeod is employed by Janssen. All other Topic Editors declare no competing interests with regards to the Research Topic subject.

The ability to understand the underlying mechanisms that drive the heterogeneity in inflammatory responses among patients suffering from immune-mediated conditions is critical. The nature of the immune mechanism ranges from the degree of immune cell activation, to the HLA genotypes, and the intensity of responses of target tissues to cytokines. High throughput experiments have generated significant information for us to facilitate the identification of disease-associated components for different complex immune-mediated conditions (e.g. psoriasis, lupus, rheumatoid arthritis, inflammatory bowel diseases), and the advances in biotechnologies and efficiency in computational resources have further promised cost-effective opportunities to simultaneously study the different aspects in the basic and translational domains of these human diseases. The critical questions we face are to provide efficient inference to integrate these datasets, and translate what we have learned from the disease-associated components to understand the heterogeneity (e.g. ethnic, gender, genetic differences) in disease manifestation and prognosis of these immune-mediated conditions. Translating and integrating big data to understand the intrinsic factors that shape the different unique natures of inflammation processes require an efficient and flexible framework to incorporate signatures of different types.

This Research Topic is intended to present and discuss technological, methodological, and conceptual advancements in immunological researches utilizing big data and/or new techniques to study the heterogeneity in immunological responses and clinical observations of immune-mediated disorders. We welcome the submission of Original Research, Systematic Review, Methods, Mini Review, Perspective, and Review articles, with potential topics including, but not limited to:

1. Designing efficient multi-omics studies for studying the pathophysiology of immune-mediated conditions

2. Advanced approaches to provide accurate and efficient HLA typing

3. Development of a generalizable and efficient framework to translate high throughput experimental data to study the variations in inflammatory responses

4. Multi-omics studies to unravel the signal transduction in the cytokine network

5. Providing a comprehensive understanding of the similarities and distinct biological features across different subgroups of patients suffering from immunological disorders

6. Applications of multi-omics to advance precision medicine in immune-mediated diseases

7. Novel in silico approaches to integrate omics information with electronic health record data

8. Machine learning tools to assess prognosis using patient’s healthcare records and/or -omic profiles

Topic Editor Dr. MacLeod is employed by Janssen. All other Topic Editors declare no competing interests with regards to the Research Topic subject.

Download ebook

Share

Editors

First Hospital, Peking University

University of Michigan

Amanda S MacLeod

Janssen Research and Development (United States)

Impact

143,336 Total views

91,678 Article views

49,748 Article downloads

1,910 Topic views

Published In

Journal Thumbnail

Frontiers in Immunology

Autoimmune and Autoinflammatory Disorders

Journal Thumbnail

Frontiers in Genetics

Computational Genomics, Human and Medical Genomics

Journal Thumbnail

Frontiers in Plant Science

Computational Genomics

Journal Thumbnail

Frontiers in Bioengineering and Biotechnology

Computational Genomics

About Frontiers Research Topics

With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author.

Suggest a topic